Menu

Drugmaker Biogen recently added a third drug to its 340B contract pharmacy restrictions for hospitals.

Biogen Adds Drug with Narrow Approval to 340B Contract Pharmacy Restrictions

December 5, 2023 Rich Daly, Editor in Chief 340B Report Views

Biopharmaceutical manufacturer Biogen recently expanded its contract pharmacy restrictions for hospitals to a third drug, after that medication garnered a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

If you are not yet a paid subscriber, please Subscribe now.

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Rich Daly

340B Outlook from Capitol Hill, Federal Courts, and the States

Four 340B Terminations, Eight Paybacks to Manufacturers in Latest Provider Audit Findings